Startseite Predicting chronic pain after major traumatic injury
Artikel Öffentlich zugänglich

Predicting chronic pain after major traumatic injury

  • Elisabeth B. Powelson , Brianna Mills , William Henderson-Drager , Millie Boyd , Monica S. Vavilala und Michele Curatolo ORCID logo EMAIL logo
Veröffentlicht/Copyright: 22. Mai 2019
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background and aims

Chronic pain after traumatic injury and surgery is highly prevalent, and associated with substantial psychosocial co-morbidities and prolonged opioid use. It is currently unclear whether predicting chronic post-injury pain is possible. If so, it is unclear if predicting chronic post-injury pain requires a comprehensive set of variables or can be achieved only with data available from the electronic medical records. In this prospective study, we examined models to predict pain at the site of injury 3–6 months after hospital discharge among adult patients after major traumatic injury requiring surgery. Two models were developed: one with a comprehensive set of predictors and one based only on variables available in the electronic medical records.

Methods

We examined pre-injury and post-injury clinical variables, and clinical management of pain. Patients were interviewed to assess chronic pain, defined as the presence of pain at the site of injury. Prediction models were developed using forward stepwise regression, using follow-up surveys at 3–6 months. Potential predictors identified a priori were: age; sex; presence of pre-existing chronic pain; intensity of post-operative pain at 6 h; in-hospital opioid consumption; injury severity score (ISS); location of trauma, defined as body region; use of regional analgesia intra- and/or post-operatively; pre-trauma PROMIS Depression, Physical Function, and Anxiety scores; in-hospital Widespread Pain Index and Symptom Severity Score; and number of post-operative non-opioid medications. After the final model was developed, a reduced model, based only on variables available in the electronic medical record was run to understand the “value add” of variables taken from study-specific instruments.

Results

Of 173 patients who completed the baseline interview, 112 completed the follow-up within 3–6 months. The prevalence of chronic pain was 66%. Opioid use increased from 16% pre-injury to 28% at 3–6 months. The final model included six variables, from an initial set of 24 potential predictors. The apparent area under the ROC curve (AUROC) of 0.78 for predicting pain 3–6 months was optimism-corrected to 0.73. The reduced final model, using only data available from the electronic health records, included post-surgical pain score at 6 h, presence of a head injury, use of regional analgesia, and the number of post-operative non-opioid medications used for pain relief. This reduced model had an apparent AUROC of 0.76, optimism-corrected to 0.72.

Conclusions

Pain 3–6 months after trauma and surgery is highly prevalent and associated with an increase in opioid use. Chronic pain at the site of injury at 3–6 months after trauma and surgery may be predicted during hospitalization by using routinely collected clinical data.

Implications

If our model is validated in other populations, it would provide a tool that can be easily implemented by any provider with access to medical records. Patients at risk of developing chronic pain could be selected for studies on preventive strategies, thereby concentrating the interventions to patients who are most likely to transition to chronic pain.

1 Introduction

Traumatic injury causes acute pain, primarily because of tissue damage. However, for unclear reasons, pain can persist beyond the acute phase after apparent healing of the injury with a prevalence ranging from 11 to 79% [1], [2], [3], [4], [5], [6], [7]. Traumatic injury may require surgery and surgery itself, even without a previous traumatic injury, is a known determinant of chronic pain [8], [9], [10], [11], [12], [13], [14], [15]. In a population-based study of surgical patients, chronic pain in the area of surgery was reported by 40.4% of the patients and moderate or severe pain was present in 18.3% of subjects [16].

Chronic pain after both traumatic injury and surgery can extensively impact clinical and socio-economic outcomes. Chronic pain is associated with substantial psychosocial comorbidities such as depression, anxiety, physical impairments, sleep disorder and high social costs [2], [7], [17]. Surgery can lead to prolonged use of opioid medication even in previously opioid-naïve patients [18], [19], [20], [21]. Opioid use for chronic pain has been associated with adverse outcomes, such as uncontrolled pain despite dose escalation, disability, higher use of the health care, psychosocial disorders and death, in the absence of demonstrated long-term benefits [22], [23], [24], [25], [26].

Given the large trauma injury burden, including the need for surgery, the high prevalence of chronic pain, suffering, psychosocial comorbidities, social costs and the generation of long-term opioid users, chronic pain after traumatic injury and surgery represents a significant public health problem.

Previous studies of chronic post-injury pain, while demonstrating the scope of the problem and identifying some risk factors, are limited by either their retrospective nature [3], [4], scope limited to specific types of injury [1], [3], [5] or lack of examination of potentially important factors, such as in-hospital management [2], [3], [7], opioid medication [2], [3], [7], pre-existing chronic pain [2], [3], [4] or psychosocial co-morbidities [3].

It is currently unclear whether predicting chronic post-injury pain is possible. If so, it is unclear if predicting chronic post-injury pain requires a comprehensive set of variables or can be achieved only with data available from the electronic medical records. In this prospective study, we examined models to predict pain at the site of injury 3–6 months after hospital discharge among adult patients after major traumatic injury requiring surgery. Two models were developed: one with a comprehensive set of predictors and one based only on variables available in the electronic medical records. If patients at risk of developing chronic post-injury pain can be identified early, preventive strategies may be investigated in the high-risk population.

2 Patients and methods

2.1 Study population and study setting

We recruited a convenience sample of patients admitted to Harborview Medical Center after traumatic injury, who underwent surgery for trauma. Harborview Medical Center is a 450-bed level-1 adult trauma center covering the five State Pacific Northwest region (Washington, Wyoming, Alaska, Montana and Idaho), with over 5,000 annual trauma admissions. The study was approved by the University of Washington Institutional Review Board. All patients gave informed consent electronically by signing their names on the consent form using the REDCap program (Research Electronic Data Capture) [27] on a hand held tablet.

Patients admitted from July 1, 2016 to December 31, 2016 were considered for enrollment if they were admitted as a trauma, according to the inclusion criteria of the Washington State Trauma Registry (Supplementary material File 1). All patients were admitted directly through the emergency department. Patients were screened via chart review every 24 h based on a list compiled by the trauma registry and approached in person by the study staff while they were hospitalized.

Patients who were less than 18 years old, unable to provide informed consent, in judicial custody, did not undergo surgery or were discharged from the emergency room or post-anesthesia care unit without admission, were excluded. Study data were collected and managed using REDCap [27].

Participation in the study did not involve any novel treatment regimens. All study participants received care according to the standards of the University of Washington Harborview Medical Center.

2.2 In-hospital assessment

Patients admitted to the hospital for surgical management were interviewed in person by the study staff after undergoing surgical intervention. We recorded gender, age, body mass index and race from the inpatient medical records. We recorded the following injury characteristics: injury severity score (ISS, range 0–75); mechanism of injury as defined in the Washington State Trauma Registry (fall, motor vehicle collision, pedestrian accident, other transportation, firearms/machinery/objects, and other); and injury at body regions with an Abbreviated Injury Scale (AIS) of at least 2 (scale 1–6), indicating a moderate or more severe injury [28].

We recorded the following variables of pre-trauma condition: presence of pre-existing pain, defined as yes/no; in case of pre-existing pain, pre-injury opioid use, defined as yes/no; the NIDA (National Institute of Drug Abuse) Assist Measure, a validated tool to screen for illicit drug use in general medical settings [29]; the PROMIS (Patient-Reported Outcomes Measurement Information System) Measures Computer Assisted Test for Depression, Anxiety, Physical function, Pain interference and Pain Behavior, reported as a T-score that is standardized to the population [30]; the Widespread Pain Index and Symptom Severity Score [31], reported as individual scores. For pre-trauma variables, we asked patients to recall their condition prior to hospitalization.

For in-hospital clinical characteristics, we recorded the following variables: intensity of post-operative pain at the site of injury 6 h after surgery, defined as numeric rating scale 0–10 (0=no pain, 10=worst pain imaginable); last current pain score before discharge (0–10); PROMIS Measures for Depression, Anxiety, Physical function, Pain interference and Pain Behavior; the Widespread Pain Index and Symptom Severity Score during hospitalization.

Regarding in-hospital clinical management, we recorded the following variables: type of surgery; number of surgeries, with surgery defined as treatment provided in the operating room necessitating care of an anesthesiologist; number of surgeries per patient; length of surgery; in-hospital opioid consumption, defined as morphine equivalent dose including parenteral and oral opioids; number of patients that used intravenous patient-controlled-analgesia; post-operative non-opioid medications as documented in the medical records; and number of patients that used regional analgesia intra- and/or post-operatively, defined as a single injection or placement of a catheter. To calculate the morphine equivalent dose, we used the guidelines of the Centers for Disease Control and Prevention for the oral equivalent doses (https://www.cdc.gov/drugoverdose/resources/data.html) and the recommendation by Gammaitoni et al. [32] for the iv equivalent doses.

2.3 Clinical management during hospitalization

The analgesic regimen after admission was determined by the admitting service, in consultation with the acute pain service as needed. The common practice of the acute pain team is to optimize medication therapy using opioid and non-opioid analgesics as well as adjunctive non-medication therapy. Rehabilitation psychology providers and spiritual care team members provide services during weekday hours.

The analgesic regimen during surgery was at discretion of the anesthesiologist. Regional anesthetic techniques are uncommonly used as the primary anesthetic at our institution, given the emergent nature and possible length of surgery. Peripheral nerve blocks are most commonly placed after surgical intervention in the post-anesthesia care unit (PACU).

In the immediate post-operative period, pain is managed by the anesthesiology team. After discharge from the PACU, pain is managed by the admitting service, with consultation from the acute pain service as needed. Physical therapy and mental health services are provided as needed, at discretion of the admitting service and/or the acute pain service.

2.4 Follow-up assessment

A single follow-up assessment was initiated at 3 months after hospital discharge to determine the presence of chronic pain at the site of trauma. Discharge from the hospital was chosen as time zero of the follow-up. Given the variation in hospital length of stay and number of surgeries, we assumed that patients reached a consistent level of recovery at the time of discharge from hospital. Participants were first sent an automated email to the address we had on file, requesting completion of an online survey through REDCap®. Non-responders were contacted via a personalized email providing a telephone number and asking for a good time to administer the survey. Subsequent follow-up occurred by a telephone call to a known telephone number. We also approached alternate contacts if provided for a maximum of three times. After three unsuccessful attempts, patients were categorized as lost to follow-up. Surveys received after 6 months were not considered.

We asked about chronic pain at the site of trauma, defined as pain of any intensity at the site of trauma within the past week. We recorded: pain intensity at the site of trauma (0=no pain, 10=worst pain imaginable); current treatment for pain including opioid medication, non-opioid medication, marijuana and non-pharmacologic modalities; scores in the PROMIS Depression, Anxiety, Physical Function, Pain interference, and Pain Behavior; as well as the Widespread Pain Index and Symptom Severity Score.

2.5 Statistical prediction

The statistical plan was determined a priori. Chronic pain at follow-up was defined as a binary variable, i.e. as the presence of pain at the site of injury as self-reported by the patient. We used follow-up surveys conducted between 3 and 6 months post-discharge because this was the timing of highest response. Potential predictors identified a priori were: age; sex; presence of pre-existing chronic pain; intensity of post-operative pain at 6 h; in-hospital opioid consumption; injury severity score (ISS); location of trauma, defined as body region; use of regional analgesia intra- and/or post-operatively; pre-trauma PROMIS Depression, Physical Function, and Anxiety scores; in-hospital Widespread Pain Index and Symptom Severity Score; number of post-operative non-opioid medications.

With regard to missing data, no potential predictors had missingness of >20%. However, missing data were missing not at random (MNAR) and were instead informative of post-surgical patient experiences. In other words, the absence of a value for a particular variable told us something about the patient. To account for the informativity of missing pain scores 6 h after surgery, pain score was transformed to an ordinal variable with a category for missing values. This approach is not appropriate for explanatory models but has been recommended for predictive models with informative missingness [33], [34], [35].

Our multivariable model predicting chronic pain 3–6 months post-discharge was constructed in using a stepwise selection approach. First, continuous candidate predictors were assessed using LOWESS (locally weighted scatterplot smoothing) plots without transformation and transformed accordingly. Associations between all candidate predictors and chronic pain were assessed using bi-variable logistic regression. Significance tests were based on the Mann-Whitney test, Fisher’s exact, or unpaired t-test with unequal variance as appropriate. A parsimonious final set of predictor variables was selected by discarding candidate variables with a p-value>0.2 on bivariate analysis. The remaining potential predictors were included in a multivariable model, and any variables that did not retain their significance at the p-value>0.2 threshold were dropped. A significance threshold of 0.2, rather than the more traditional threshold of 0.05 found in explanatory modeling, was selected to increase statistical power and avoid “underfitting” a model with an erroneously small number of variables [36]. After the final model was developed, a reduced model, based only on variables available in the electronic medical record, was run to understand the “value add” of variables taken from study-specific instruments. The variables available in the electronic medical record were pain score 6 h post-surgery, presence of a head injury with AIS of 2 or greater, use of regional analgesia, and number of non-opioid medications. A sensitivity analysis used a best-subsets approach and leaps-and-bounds algorithm appropriate for logistic regression to select a parsimonious final model from all candidate predictors.

For the assessment of model performance, we tested model calibration (how well predicted outcomes matched known outcomes) using a Hosmer-Lemeshow goodness-of-fit test with 10 groups and a calibration plot. To assess model discrimination (how well the model distinguishes between subjects with and without chronic pain), we calculated the apparent and optimism-corrected c-statistic (area under the curve) for both the final and final reduced model, and compared them using the Delong method [37]. The apparent c-statistic, or area under the curve, quantifies the accuracy of the prediction model in the study sample. The optimism-corrected c-statistic is an estimate of how well the prediction model will perform in a new sample. We also calculated the index of prediction accuracy (IPA). The IPA is a rescaled Brier score combining discrimination and calibration into a single value, with 1.00 representing a perfect prediction model and an IPA<0 indicating a useless model [38]. Operating characteristics (sensitivity and specificity) of the model were calculated for prediction cut-points at 0.25, 0.50, and 0.75. For internal validation (the reproducibility of results within the original study cohort), we repeated these assessments using a bootstrapped resampling with replacement method for 200 iterations and calculated the overfitting percentage. All statistical models were run in Stata 15 (Statacorp LP, College Station, USA).

3 Results

3.1 Study flow

From July 1, 2016 to December 31, 2016, 208 patients were approached by the study staff and 183 (88%) consented. Of 183 recruited patients, 173 (96%) completed the baseline interview. One hundred fifteen (66%) completed the follow-up survey within 3–6 months, with a mean of 127.5 days and a standard deviation of 30.0 days. Of the 115 patients who completed the 3–6 months survey, three patients did not answer the question regarding chronic pain and were excluded from the prediction model.

3.2 Clinical characteristics and management

Demographic and clinical characteristics for participants with complete baseline data and for participants with completed follow-up at 3–6 months are presented in Table 1. Table 2 displays demographic and clinical characteristics for participants with complete baseline data and for all patients admitted to Harborview Medical Center during the same time period and who underwent surgery, as recorded in the Harborview Medical Center Trauma Registry. In-hospital management is presented in Table 3. In our final cohort for prediction, 66% of patients had pain at the site of trauma 3–6 months after hospital discharge (74 of the 112 patients who answer the question regarding chronic pain). The clinical characteristics at follow-up are presented in Table 4.

Table 1:

Demographic and clinical characteristics for participants with complete baseline data and for participants with completed follow-up at 3–6 months.

Participants with complete baseline data (n=173) Participants with follow-up at 3–6 months (n=115)
Demographics
 Female 73 (42%) 49 (43%)
 Male 100 (58%) 66 (57%)
 Age 47 (30–61) 49 (28–62)
 BMI 26 (23–30) 26 (22–30)
 Race
  Non-Hispanic white 118 (68%) 81 (70%)
  Non-Hispanic African American 12 (7%) 7 (6%)
  Hispanic 16 (9%) 13 (11%)
  Non-Hispanic Other 20 (12%) 11 (9%)
  Not reported 7 (4%)
Injury characteristicsa
 Injury severity score 10 (5–17) 10 (5–18.5)
 Mechanism of injury
  Fall 60 (35%) 38 (33%)
  Motor vehicle collision 50 (29%) 35 (30%)
  Pedestrian accident 19 (11%) 15 (13%)
  Other transportation 13 (7.5%) 8 (7%)
  Firearms/machinery/objects 14 (8%) 7 (6%)
  Other 13 (7.5%) 9 (8%)
 Injury locations with AIS ≥2b
  Head 22 (13%) 15 (16%)
  Face 2 (1%) 1 (1%)
  Chest 33 (19%) 24 (21%)
  Abdomen 11 (6%) 8 (7%)
  Extremities 73 (42%) 53 (47%)
  External soft tissue injury 5 (3%) 4 (3%)
  Multiple injuries, AIS ≥2 63 (36%) 43 (38%)
Pre-injury clinical characteristicsc
 Presence of pre-injury pain 55 (33%) 35 (31%)
 Pre-injury opioid use for pain 26 (15%) 19 (16%)
 NIDA Assist Measure (patients at risk, score ≥4) 30 (17%) 17 (15%)
PROMIS Baseline t-scores
 Depression 48 (34–55) 48 (39–54)
 Anxiety 49 (39–58) 50 (42–57)
 Physical function 53 (45–57) 53 (45–57)
 Pain interferenced 47 (39–58) 47 (39–56)
 Pain behaviord 50 (35–57) 48 (35–57)
WPI 0 (0–2) 1 (0–2)
Symptom severity score 2 (0–5) 2 (1–5)
In-hospital clinical characteristics
 Post-surgical pain score at 6 he 5 (4–8) 5 (3–8)
 Last pain score prior to dischargee 5 (3–7) 5 (2.5–7)
 WPI 3 (1–5) 3 (2–5)
 Symptom severity scoref 5 (3–7) 5 (3–8)
  1. aData available in 169 patients.

  2. bIndividuals may have multiple injury locations.

  3. cRecorded during hospitalization, by asking patients to recall their condition prior to hospitalization.

  4. dData available in 96 and 63 patients with complete baseline data and completed follow-up at 3–6 month, respectively; these figures are lower than the overall cohort because the parameters were collected only for patients with pain.

  5. eNumerical rating scale, 0–10, current pain at the site of trauma.

  6. fData available in 165 for patients with complete baseline data.

  7. BMI=body-mass index; AIS=abbreviated injury scale; WPI=Widespread Pain Index.

  8. Categorical data are presented as number of patients (percent in parentheses). Numerical data are presented as median values (interquartile range in parentheses).

Table 2:

Demographic and clinical characteristics for participants with complete baseline data and for patients admitted to Harborview Medical Center during the same time period and who underwent surgery, as recorded in the Harborview Medical Center Trauma Registry.

Participants with complete baseline data (n=173) Trauma Registry Surgical Admissions (n=1,581)
Demographics
 Female 73 (42%) 472 (30%)
 Male 100 (58%) 1,109 (70%)
 Age 47 (30–61) 44 (28–61)
 BMI 26 (23–30) 26 (23–30)
 Race
  White 134 (77%) 1,251 (80%)
  Black 12 (7%) 130 (8%)
  Other 20 (12%) 159 (10%)
  Not reported 7 (4%) 41 (2%)
Injury characteristicsa
 Injury severity score 10 (5–17) 10 (5–21)
 Mechanism of injury
  Fall 60 (35%) 487 (31%)
  Motor vehicle collision 50 (29%) 279 (18%)
  Pedestrian accident 19 (11%) 106 (7%)
  Other transportation 13 (7.5%) 387 (25%)
  Firearms/machinery/objects 14 (8%) 191 (12%)
  Other 13 (7.5%) 131 (8%)
 Injury locations with AIS ≥2b
  Head 22 (13%) 345 (22%)
  Face 2 (1%) 178 (11%)
  Chest 33 (19%) 355 (22%)
  Abdomen 11 (6%) 201 (13%)
  Extremities 73 (42%) 1,024 (65%)
  External soft tissue injury 5 (3%) 172 (11%)
  1. aData available in 169 patients for patients with complete baseline data.

  2. bIndividuals may have multiple injury locations.

  3. BMI=body-mass index; AIS=abbreviated injury scale.

  4. Categorical data are presented as number of patients (percent in parentheses). Numerical data are presented as median values (interquartile range in parentheses).

Table 3:

In-hospital management for participants with complete baseline data and for participants with completed follow-up at 3–6 months.

Participants with complete baseline data (n=173) Participants with completed follow-up at 3–6 months (n=115) Participants with pain at 3–6 months follow-up (n=74)
Surgery typea
 General surgery 23 (8%) 17 (8%) 1 (1%)
 Orthopedic extremity surgery 183 (62%) 133 (61%) 60 (81%)
 Orthopedic pelvis surgery 13 (4%) 8 (4%) 3 (4%)
 Spine surgery 30 (10.2%) 22 (10%) 5 (7%)
 Plastic surgery 21 (7%) 18 (8%) 3 (4%)
 Other surgeryb 25 (8%) 19 (9%) 2 (3%)
Length of stay in days 9 (4–15) 9 (4–15) 9 (4–13)
Number of surgeries per patient 1 (1–2) 1 (1–2) 1 (1–2)
Length of surgery in minutesc 201 (151–277) 200 (145–266) 213 (157–297)
Total opioid dose during surgery in morphine equivalent 251 (200–478) 252 (152–501) 252 (152–453)
Daily opioid dose in morphine equivalent per day 127 (80–190) 127 (74–197) 134 (80–197)
Patients with patient-controlled IV analgesia 13 (8%) 10 (9%) 4 (5%)
Patients on methadone for pain 9 (5%) 6 (5%) 4 (5%)
Number of post-operative non-opioid pain medications 1 (0–1) 1 (0–1) 0.5 (0–1)
Lidocaine patch 12 (7%) 9 (8%) 5 (7%)
Gabapentin 78 (45%) 50 (44%) 32 (43%)
Ketorolac 12 (7%) 8 (7%) 2 (3%)
Ketamine 6 (3%) 4 (4%) 3 (4%)
Patients with regional analgesiad 49 (28%) 36 (31%) 30 (41%)
 Epidural 3 (2%) 1 (1%) 0
 Brachial Plexus 3 (2%) 2 (2%) 3 (4%)
 Ankle 2 (1%) 0 0
 Femoral 8 (5%) 6 (5%) 5 (7%)
 Sciatic [with Saphenous]e 33 [5] (19%) 27 [4] (23%) 22 [4] (30%)
  1. aThere were patients with multiple surgeries.

  2. bHand, cranial, ophthalmologic, oral-maxillofacial and vascular surgery.

  3. cMedian of within-subject median.

  4. dThe block was performed before surgery in four patients and immediately after surgery in the remaining patients. In 35 patients (71%) a catheter was placed for continuous infusion, which was discontinued after a median (interquartile range) of 3 (2–3) days.

  5. eIt is standard clinical practice to place saphenous blocks only in the setting of sciatic blocks in our institution.

  6. Categorical data are presented as number of patients (percent in parentheses). Numerical data are presented as median values (interquartile range in parentheses).

Table 4:

Clinical characteristics at follow-up.

After 3–6 months (n=115)
Patients with pain at site of traumaa 74 (66%)
Pain intensityb,c 4 (2–6)
Current treatment for pain
 Opioids 32 (28%)
 Non-opioids 38 (33%)
 Marijuana 34 (30%)
 Non-pharmacologic modalities 39 (34%)
PROMIS t-scores
 Depression 51 (44–59)
 Anxiety 51 (43–59)
 Physical function 39 (31–47)
 Pain interferenced 61 (56–67)
 Pain behaviord 58 (53–61)
WPI 1 (0–2)
Symptom severity score 3 (1–6)
  1. aData available in 112 patients for the 3–6 month follow-up, as three patients did not answer the question whether they have pain.

  2. bNumerical rating scale, 0–10.

  3. c n=74 and 59 for patients with complete baseline data and completed follow-up at 3–6 month, respectively; these figures are lower than the overall cohort because the pain score was collected only for patients with pain; there is a missing value at 3–6-month follow-up.

  4. dData pertaining only to patients with pain.

  5. WPI=Widespread Pain Index.

  6. Categorical data are presented as number of patients (percent in parentheses). Numerical data are presented as median (interquartile range in parentheses).

3.3 Prediction model

Table 5 shows the results of our initial bivariate and multivariable models for all candidate predictors. The final prediction model (Table 6) included post-surgical pain score at 6 h, presence of a head injury, use of regional analgesia, PROMIS depression score, Widespread Pain Index score, and the number of post-operative non-opioid medications used for pain relief.

Table 5:

Model selection results for candidate predictors.

Candidate predictor Variable definition Univariate models
Multivariate model
β SE p-Value β SE p-Value
Age Age in years 0.78 0.49 0.11 0.51 0.55 0.35
Male sex 0=Female/1=male −0.52 0.41 0.21
Pre-existing chronic pain 3 Levels
0=No pre-existing pain Ref
1=Pre-existing pain not treated by opiates 0.85 0.69 0.22
2=Pre-existing pain treated with opiates −0.30 0.52 0.57
Post-surgery pain score at 6 h Pain score 5–7 h post-primary surgery
0=no pain score at 5–7 h postoperativelya 1.53 0.88 0.08 2.02 1.00 0.04
1=0–2 Ref. Ref.
2=3–5 1.73 1.03 0.10 2.37 1.16 0.04
3=6–8 2.42 1.15 0.04 2.61 1.41 0.07
4=9–10 2.86 1.36 0.04 3.11 1.53 0.04
Mean in-hospital opioid dose per day Total opioids in hospital, divided by length of stay (MME/day) −0.001 0.002 0.45
Injury severity score Continuous, 0–75 −0.02 0.02 0.23
Injury location AIS score ≥2, yes/no
 Head −0.66 0.47 0.16 −0.76 0.53 0.15
 Face AIS score ≥2, yes/no −0.45 0.80 0.57
 Chest AIS score ≥2, yes/no 0.35 0.48 0.47
 Abdominal AIS score ≥2, yes/no −0.59 0.50 0.24
 Extremity AIS score ≥2, yes/no 0.68 0.50 0.17 −0.07 0.56 0.91
 External soft tissue AIS score ≥2, yes/no −0.02 0.78 0.98
Regional analgesia Yes/no 1.29 0.51 0.01 1.62 0.71 0.02
PROMIS depression T-score, centered at 50 0.04 0.02 0.02 0.03 0.02 0.18
PROMIS physical function T-score, centered at 50 −0.004 0.02 0.85
PROMIS anxiety T-score, centered at 50 0.001 0.02 0.97
Widespread Pain Index 0–19 0.16 0.08 0.05 0.13 0.09 0.14
Symptom severity 0–12 0.04 0.06 0.57
Number of post-operative non-opioids 0–4 −0.39 0.25 0.12 −0.42 0.34 0.22
Lidocaine patch Yes/no −0.48 0.71 0.49
Gabapentin Yes/no −0.17 0.40 0.68
Ketorolac Yes/No −1.91 0.85 0.02 −0.83 1.00 0.41
Lidocaine i.v. Yes/no −1.13 0.94 0.23
Ketamine Yes/no 0.45 1.18 0.70
  1. a n=76.

  2. MME=mean morphine equivalents.

Table 6:

Final prediction model.

Candidate predictor Variable definition Prediction coefficients
β SE
Post-surgery pain score at 6 h Pain score 5–7 h post-primary surgery
0=no pain score at 5–7 h postoperativelya 2.19 0.92
1=0–2 Ref.
2=3–5 2.68 1.08
3=6–8 2.71 1.37
4=9–10 3.44 1.51
Head injury AIS score ≥2, yes/no −0.75 0.52
Regional analgesia Yes/no 1.71 0.66
PROMIS depression T-score, centered at 50 0.03 0.02
Widespread Pain Index 0–19 0.16 0.08
Number of post-operative non-opioids 0–4 −0.57 0.27
Constant n/a −3.30 1.32
  1. a n=76.

The apparent area under the ROC curve (AUROC) of 0.78 for predicting pain 3–6 months post-discharge was optimism-corrected to an AUROC of 0.73 (Fig. 1). The Hosmer-Lemeshow test showed acceptable fit, as did the calibration plot (Fig. 2). The model overfitting was 7.3%. The IPA for the final model was 0.233.

Fig. 1: 
            Discrimination of prediction scores for post-discharge chronic pain at 3–6 months, using study variables significant at p<0.2 and a reduced set of significant variables drawn from the electronic health records (EHR). The apparent area under the ROC curve (AUROC) based on significant study variables was 0.78, and optimism-corrected to 0.73. The AUROC based on a reduced set of EHR variables was 0.76, and optimism-corrected to 0.72.
Fig. 1:

Discrimination of prediction scores for post-discharge chronic pain at 3–6 months, using study variables significant at p<0.2 and a reduced set of significant variables drawn from the electronic health records (EHR). The apparent area under the ROC curve (AUROC) based on significant study variables was 0.78, and optimism-corrected to 0.73. The AUROC based on a reduced set of EHR variables was 0.76, and optimism-corrected to 0.72.

Fig. 2: 
            Calibration of prediction scores for post-discharge chronic pain at 3–6 months.
Fig. 2:

Calibration of prediction scores for post-discharge chronic pain at 3–6 months.

The reduced final model, using only data available from the electronic health records, included post-surgical pain score at 6 h, presence of a head injury, use of regional analgesia, and the number of post-operative non-opioid medications used for pain relief. The apparent AUROC of 0.76 was optimism-corrected to 0.72 (Fig. 1). The difference between the final and reduced final models was not statistically significant (p-value=0.44). The IPA for the reduced final model was 0.157, 7.6 percentage points lower than the model that included measures of depression and WPI.

The sensitivity and specificity of the model at prediction cut-points of 0.25, 0.5, and 0.75 is presented in Table 7. The sensitivity analysis using the best-subsets approach chose use of regional analgesia, PROMIS depression score, and the use of ketorolac as the best multivariable model, based on penalized Akaike information criterion (AIC). This model had an apparent AUROC of 0.70 (Fig. 3) and an IPA of 0.134.

Table 7:

Sensitivity and specificity of the model at prediction cut-points of 0.25, 0.5, and 0.75.

Prediction cut-point
0.25 0.5 0.75
Patients
 True positive 72 65 36
 False positive 31 21 5
 True negative 7 17 33
 False negative 0 7 36
Operating characteristics
 Sensitivity (%) 100.0 90.3 50.0
 Specificity (%) 18.4 44.7 86.7
 Positive predictive value (%) 69.9 75.6 87.8
 Negative predictive value (%) 100.0 70.8 47.8
Fig. 3: 
            Discrimination of prediction scores for post-discharge chronic pain at 3–6 months, using study variables significant at p<0.2 and study variables chosen by vselect procedure and penalized Akaike Information Criterion (AIC). The apparent area under the ROC curve (AUROC) based on significant study variables was 0.78, and the AUROC based on vselect was 0.70.
Fig. 3:

Discrimination of prediction scores for post-discharge chronic pain at 3–6 months, using study variables significant at p<0.2 and study variables chosen by vselect procedure and penalized Akaike Information Criterion (AIC). The apparent area under the ROC curve (AUROC) based on significant study variables was 0.78, and the AUROC based on vselect was 0.70.

4 Discussion

In this study, we present a model to predict chronic pain at the site of injury after trauma. We found that pain 3–6 months after discharge can be predicted during hospitalization with reasonably high accuracy based on data available from the electronic health records.

4.1 Pain and co-morbidities at follow-up

We found that 66% of patients in our sample of trauma patients undergoing surgery had pain at the site of trauma 3–6 months after hospital discharge. Opioids were used in 28% of patients after 3–6 months post-discharge. This represents an increase from the 16% opioid use before the injury (Tables 1 and 4). Thirty percent of patients used marijuana for their pain after 3–6 months. There was a worsening in pain behavior, pain interference and physical function from baseline to follow-up (Tables 1 and 4).

Changes in pain-related management and co-morbidities were not the main aim of the present study. We therefore did not test for statistical significance. However, research in this area has been sparse and our findings have public health relevance. The data indicate that traumatic injury can lead to an increase in opioid use, so that previously opioid-naïve patients may become chronic opioid users. This finding is concerning in the light of the doubts on the long-term efficacy of opioids and concerns about their safety [22], [23], [24], [25], [26]. Because of the very limited evidence of efficacy of marijuana in chronic pain, also the finding of 30% use to treat pain at 3–6 months is concerning and deserves further investigation. As we did not record pre-injury marijuana use, we cannot however determine the number of new marijuana users in our cohort. It is unclear whether the decrease in physical function at follow-up is the result of pain, trauma, surgery or a combination of these factors. Investigating physical recovery after trauma and its relationship with pain is another relevant avenue of future research.

4.2 Prediction model

Our final predictive model included post-surgical pain score at 6 h, presence of a head injury, use of regional analgesia, PROMIS depression score, Widespread Pain Index score and the number of post-operative non-opioid medications used for pain relief. Our prediction model performed well, with an apparent area under the ROC curve (AUROC) of 0.78 that was optimism-corrected to 0.73. Although the index of prediction accuracy was better for the full model than the reduced, there was no statistically significant difference in the predictive ability between the full model and the model that included only variables that are routinely collected as part of the medical records. Taken as a whole, this suggests that patients at risk of chronic pain can be identified (1) with reasonable accuracy and (2) without the use of variables that are typically employed for research purposes.

While our predictive approach precludes inference on any single predictor [34], the majority of variables in our model predicting pain have been identified also in previous studies as important factors in the development of chronic pain. The presence of pain score at 6 h post-operatively as an element of the model is consistent with prior literature on chronic post-surgical pain, whereby high levels of acute pain were associated with chronic pain [13], [39], [40]. The area of injury (head) contributed to our predictive model. This finding cannot be interpreted in the frame of a predictive study and requires confirmation by future studies. The presence of regional analgesia among the predictors of chronic pain may be the result of the clinical context and the criteria for offering the treatment to patient. Patients with most severe acute pain were more likely to receive regional analgesia and may have been also more likely to develop chronic pain. The inclusion of depression in the predictive model reflects the well-established notion that patients with depressive symptoms are more prone to adverse pain outcomes. The predictive value of the widespread pain index is consistent with prior literature on the association between widespread pain index and poor pain outcomes [41], [42]. Finally, the finding on the number of non-opioid pain medications is again difficult to explain in a predictive model and requires investigations that specifically address the contribution of acute pain management to the development of chronic pain.

4.3 Strengths and limitations

To our knowledge, this is the first study on chronic post-injury pain that considered a comprehensive set of potential predictors, including pre-injury, in-hospital and clinical management variables. The prospective study design allowed for inclusion of variables not routinely collected on trauma patients and prevented recall bias for most variables. The retention at follow-up was challenging but could achieve the acceptable rate of 66% of completed follow-up data at 3–6 months, of the number of participants with complete baseline data. Follow-up variables were not limited to pain but included variables of pain-relevant comorbidities.

A larger patient population would have allowed the analysis of a larger set of potential predictors. As with any study of a convenience sample of patients, selection bias may limit the generalizability of findings to the broader trauma population. Based on available data (Table 2) we believe that our results are generalizable, pending external validation. In this regard, our model needs to be validated in other populations to confirm generalizability. However, our focus on variables that are routinely collected in electronic medical records implies that a multi-site validation should be feasible, and our model can be easily implemented by any provider with access to medical records.

The predictive rather than explanatory nature of our model prevents the interpretation of the contribution of individual factors. Part of the pre-injury variables had to be collected during hospitalization, relying on patients’ recall of their pre-injury state. While this was unavoidable, the validity of this approach is uncertain.

5 Conclusions and implications

Chronic pain after trauma and surgery is highly prevalent and associated with an increase in opioid use, worsening in pain behavior, pain interference and physical function. Chronic pain at the site of injury at 3–6 months after trauma and surgery may be predicted during hospitalization by routinely collected clinical data. Future explanatory studies may shed more light on the potential determinants of chronic post-injury pain, allowing the investigation of potential preventive strategies.

If our model is validated in other populations, it would provide a tool that can be easily implemented by any provider with access to medical records. Patients at risk of developing chronic pain could be selected for studies on preventive strategies, thereby concentrating the interventions to patients who are most likely to transition to chronic pain.


Corresponding author: Prof. Michele Curatolo, MD, PhD, Department of Anesthesiology and Pain Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, USA; and Harborview Injury Prevention and Research Center, Seattle, WA, USA, Phone: +1 206 543 2568

Acknowledgments

We thank Leah Jarvik, Carlos Escutia and Samuel Park for contributing in the data collection, and Vivian H. Lyons for her contributions to the statistical support.

  1. Authors’ statements

  2. Research funding: The study was funded by the Harborview Injury Prevention and Research Center and the Department of Anesthesiology and Pain Medicine of the University of Washington.

  3. Conflict of interest: No conflict of interest.

  4. Informed consent: Informed consent has been obtained from all individuals included in this study.

  5. Ethical approval: The research related to human use complies with all the relevant national regulations, institutional policies and was performed in accordance with the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional review board.

References

[1] Gordy S, Fabricant L, Ham B, Mullins R, Mayberry J. The contribution of rib fractures to chronic pain and disability. Am J Surg 2014;207:659–62; discussion 62–3.10.1016/j.amjsurg.2013.12.012Suche in Google Scholar PubMed

[2] Jenewein J, Moergeli H, Wittmann L, Buchi S, Kraemer B, Schnyder U. Development of chronic pain following severe accidental injury. Results of a 3-year follow-up study. J Psychosom Res 2009;66:119–26.10.1016/j.jpsychores.2008.07.011Suche in Google Scholar PubMed

[3] Rbia N, van der Vlies CH, Cleffken BI, Selles RW, Hovius SER, Nijhuis THJ. High prevalence of chronic pain with neuropathic characteristics after open reduction and internal fixation of ankle fractures. Foot Ankle Int 2017;38:987–96.10.1177/1071100717712432Suche in Google Scholar PubMed

[4] Rivara FP, Mackenzie EJ, Jurkovich GJ, Nathens AB, Wang J, Scharfstein DO. Prevalence of pain in patients 1 year after major trauma. Arch Surg 2008;143:282–7.10.1001/archsurg.2007.61Suche in Google Scholar PubMed

[5] Rosenbloom BN, Katz J, Chin KY, Haslam L, Canzian S, Kreder HJ, McCartney CJ. Predicting pain outcomes after traumatic musculoskeletal injury. Pain 2016;157:1733–43.10.1097/j.pain.0000000000000580Suche in Google Scholar PubMed

[6] Rosenbloom BN, Khan S, McCartney C, Katz J. Systematic review of persistent pain and psychological outcomes following traumatic musculoskeletal injury. J Pain Res 2013;6:39–51.10.2147/JPR.S38878Suche in Google Scholar PubMed PubMed Central

[7] Trevino C, Harl F, Deroon-Cassini T, Brasel K, Litwack K. Predictors of chronic pain in traumatically injured hospitalized adult patients. J Trauma Nurs 2014;21:50–6.10.1097/JTN.0000000000000032Suche in Google Scholar PubMed

[8] Gjeilo KH, Stenseth R, Wahba A, Lydersen S, Klepstad P. Chronic postsurgical pain in patients 5 years after cardiac surgery: a prospective cohort study. Eur J Pain 2017;21:425–33.10.1002/ejp.918Suche in Google Scholar PubMed

[9] Wildgaard K, Ringsted TK, Hansen HJ, Petersen RH, Kehlet H. Persistent postsurgical pain after video-assisted thoracic surgery – an observational study. Acta Anaesthesiol Scand 2016;60:650–8.10.1111/aas.12681Suche in Google Scholar PubMed

[10] Kainu JP, Halmesmäki E, Korttila KT, Sarvela PJ. Persistent pain after cesarean delivery and vaginal delivery: a prospective cohort study. Anesth Analg 2016;123:1535–45.10.1213/ANE.0000000000001619Suche in Google Scholar PubMed

[11] Pokkinen SM, Nieminen K, Yli-Hankala A, Kalliomäki M-L. Persistent posthysterectomy pain: a prospective, observational study. Eur J Anaesthesiol 2015;32:718–24.10.1097/EJA.0000000000000318Suche in Google Scholar PubMed

[12] Joris JL, Georges MJ, Medjahed K, Ledoux D, Damilot G, Ramquet CC, Coimbra CI, Kohnen LP, Brichant JF. Prevalence, characteristics and risk factors of chronic postsurgical pain after laparoscopic colorectal surgery: retrospective analysis. Eur J Anaesthesiol 2015;32:712–7.10.1097/EJA.0000000000000268Suche in Google Scholar PubMed

[13] Hoofwijk DMN, Fiddelers AAA, Peters ML, Stessel B, Kessels AGH, Joosten EA, Gramke H-F, Marcus MAE. Prevalence and predictive factors of chronic postsurgical pain and poor global recovery 1 year after outpatient surgery. Clin J Pain 2015;31:1017–25.10.1097/AJP.0000000000000207Suche in Google Scholar PubMed

[14] Andersen KG, Duriaud HM, Jensen HE, Kroman N, Kehlet H. Predictive factors for the development of persistent pain after breast cancer surgery. Pain 2015;156:2413–22.10.1097/j.pain.0000000000000298Suche in Google Scholar PubMed

[15] Puolakka PA, Rorarius MG, Roviola M, Puolakka TJ, Nordhausen K, Lindgren L. Persistent pain following knee arthroplasty. Eur J Anaesthesiol 2010;27:455–60.10.1097/EJA.0b013e328335b31cSuche in Google Scholar PubMed

[16] Johansen A, Romundstad L, Nielsen CS, Schirmer H, Stubhaug A. Persistent postsurgical pain in a general population: prevalence and predictors in the Tromsø study. Pain 2012;153:1390–6.10.1016/j.pain.2012.02.018Suche in Google Scholar PubMed

[17] Parsons B, Schaefer C, Mann R, Sadosky A, Daniel S, Nalamachu S, Stacey BR, Nieshoff EC, Tuchman M, Anschel A. Economic and humanistic burden of post-trauma and post-surgical neuropathic pain among adults in the United States. J Pain Res 2013;6:459–69.10.2147/JPR.S44939Suche in Google Scholar PubMed PubMed Central

[18] Brummett CM, Waljee JF, Goesling J, Moser S, Lin P, Englesbe MJ, Bohnert AS, Kheterpal S, Nallamothu BK. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg 2017;152:e170504.10.1001/jamasurg.2017.0504Suche in Google Scholar PubMed PubMed Central

[19] Carroll I, Barelka P, Wang CK, Wang BM, Gillespie MJ, McCue R, Younger JW, Trafton J, Humphreys K, Goodman SB, Dirbas F, Whyte RI, Donington JS, Cannon WB, Mackey SC. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesth Analg 2012;115:694–702.10.1213/ANE.0b013e31825c049fSuche in Google Scholar PubMed

[20] Clarke H, Soneji N, Ko DT, Yun L, Wijeysundera DN. Rates and risk factors for prolonged opioid use after major surgery: population based cohort study. BMJ 2014;348:g1251.10.1136/bmj.g1251Suche in Google Scholar PubMed PubMed Central

[21] Rozet I, Nishio I, Robbertze R, Rotter D, Chansky H, Hernandez AV. Prolonged opioid use after knee arthroscopy in military veterans. Anesth Analg 2014;119:454–9.10.1213/ANE.0000000000000292Suche in Google Scholar PubMed

[22] Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain 2006;125:172–9.10.1016/j.pain.2006.06.009Suche in Google Scholar PubMed

[23] Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305:1315–21.10.1001/jama.2011.370Suche in Google Scholar PubMed

[24] Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010;152:85–92.10.7326/0003-4819-152-2-201001190-00006Suche in Google Scholar PubMed PubMed Central

[25] Deyo RA, Von Korff M, Duhrkoop D. Opioids for low back pain. BMJ 2015;350:g6380.10.1136/bmj.g6380Suche in Google Scholar PubMed PubMed Central

[26] Birke H, Ekholm O, Sjogren P, Kurita GP, Hojsted J. Long-term opioid therapy in Denmark: a disappointing journey. Eur J Pain 2017;21:1516–27.10.1002/ejp.1053Suche in Google Scholar PubMed

[27] Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42: 377–81.10.1016/j.jbi.2008.08.010Suche in Google Scholar PubMed PubMed Central

[28] Greenspan L, McLellan BA, Greig H. Abbreviated Injury Scale and Injury Severity Score: a scoring chart. J Trauma 1985;25:60–4.10.1097/00005373-198501000-00010Suche in Google Scholar PubMed

[29] McNeely J, Strauss SM, Wright S, Rotrosen J, Khan R, Lee JD, Gourevitch MN. Test-retest reliability of a self-administered Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients. J Subst Abuse Treat 2014;47:93–101.10.1016/j.jsat.2014.01.007Suche in Google Scholar PubMed PubMed Central

[30] Cook KF, Jensen SE, Schalet BD, Beaumont JL, Amtmann D, Czajkowski S, Dewalt DA, Fries JF, Pilkonis PA, Reeve BB, Stone AA, Weinfurt KP, Cella D. PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions. J Clin Epidemiol 2016;73:89–102.10.1016/j.jclinepi.2015.08.038Suche in Google Scholar PubMed PubMed Central

[31] Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 2011;38:1113–22.10.3899/jrheum.100594Suche in Google Scholar PubMed

[32] Gammaitoni AR, Fine P, Alvarez N, McPherson ML, Bergmark S. Clinical application of opioid equianalgesic data. Clin J Pain 2003;19:286–97.10.1097/00002508-200309000-00002Suche in Google Scholar PubMed

[33] Sarle WS. Prediction with Missing Inputs. In: Wang P, editor. JCIS 98 Proceedings, Durham, NC: JCIS 98 Proceedings, 1998:399–402.Suche in Google Scholar

[34] Shmueli G. To explain or to predict? Stat Sci 2010;25:289–310.10.22182/pr.2532010.16Suche in Google Scholar

[35] Ding Y, Simonoff J. An investigation of missing data methods for classification trees applied to binary response data. J Mach Learn Res 2010;11:131–70.Suche in Google Scholar

[36] Steyerberg EW. Clinical prediction models, 1st ed. New York, NY: Springer New York, 2009.Suche in Google Scholar

[37] DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837–45.10.2307/2531595Suche in Google Scholar

[38] Kattan M, Gerds T. The index of prediction accuracy: an intuitive measure useful for evaluating risk prediction models. Diagnostic Progn Res 2018;2:7.10.1186/s41512-018-0029-2Suche in Google Scholar PubMed PubMed Central

[39] Bayman EO, Parekh KR, Keech J, Selte A, Brennan TJ. A prospective study of chronic pain after thoracic surgery. Anesthesiology 2017;126:938–51.10.1097/ALN.0000000000001576Suche in Google Scholar PubMed PubMed Central

[40] Guimarães-Pereira L, Farinha F, Azevedo L, Abelha F, Castro-Lopes J. Persistent postoperative pain after cardiac surgery: incidence, characterization, associated factors and its impact in quality of life. Eur J Pain 2016;20:1433–42.10.1002/ejp.866Suche in Google Scholar PubMed

[41] Brummett CM, Janda AM, Schueller CM, Tsodikov A, Morris M, Williams DA, Clauw DJ. Survey criteria for fibromyalgia independently predict increased postoperative opioid consumption after lower-extremity joint arthroplasty: a prospective, observational cohort study. Anesthesiology 2013;119:1434–43.10.1097/ALN.0b013e3182a8eb1fSuche in Google Scholar PubMed PubMed Central

[42] Janda AM, As-Sanie S, Rajala B, Tsodikov A, Moser SE, Clauw DJ, Brummett CM. Fibromyalgia survey criteria are associated with increased postoperative opioid consumption in women undergoing hysterectomy. Anesthesiology 2015;122:1103–11.10.1097/ALN.0000000000000637Suche in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/sjpain-2019-0040).


Received: 2019-03-06
Revised: 2019-04-17
Accepted: 2019-04-20
Published Online: 2019-05-22
Published in Print: 2019-07-26

©2019 Scandinavian Association for the Study of Pain. Published by Walter de Gruyter GmbH, Berlin/Boston. All rights reserved.

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial comments
  3. Information, back pain, and radiology
  4. Painful Willis-Ekbom disease: unbearable and distinct form of restless legs?
  5. Systematic review
  6. The effect of exercise therapy combined with psychological therapy on physical activity and quality of life in patients with painful diabetic neuropathy: a systematic review
  7. Clinical pain research
  8. A 4-year follow-up of non-freezing cold injury with cold allodynia and neuropathy in 26 naval soldiers
  9. Predicting chronic pain after major traumatic injury
  10. Dynamic assessment of the pupillary reflex in patients on high-dose opioids
  11. Decline of substance P levels after stress management with cognitive behaviour therapy in women with the fibromyalgia syndrome
  12. Characterization of painful Restless Legs Syndrome sensations in an English-speaking South African population
  13. Opioid prescribing habits differ between Denmark, Sweden and Norway – and they change over time
  14. Psychological factors can cause false pain classification on painDETECT
  15. Are attitudes about pain related to coping strategies used by adolescents in the community?
  16. Field testing of the revised neuropathic pain grading system in a cohort of patients with neck and upper limb pain
  17. Patient reported outcomes and neuropsychological testing in patients with chronic non-cancer pain in long-term opioid therapy: a pilot study
  18. Observational studies
  19. Lessons learned from piloting a pain assessment program for high frequency emergency department users
  20. The Portuguese 35-item Survey of Pain Attitudes applied to Portuguese women with Endometriosis
  21. Original experimental
  22. Development of a new bed-side-test assessing conditioned pain modulation: a test-retest reliability study
  23. Test-retest repeatability of questionnaire for pain symptoms for school children aged 10–15 years
  24. Unique brain regions involved in positive versus negative emotional modulation of pain
  25. What decreases low back pain? A qualitative study of patient perspectives
  26. Cutaneous nociceptive sensitization affects the directional discrimination – but not the 2-point discrimination
  27. Educational case report
  28. A painful foot with diagnostic and therapeutic consequences
  29. Short communications
  30. Educational interventions to improve medical students’ knowledge of acute pain management: a randomized study
  31. Possible inflammatory pain biomarkers in postamputation pain
  32. An online investigation into the impact of adding epidemiological information to imaging reports for low back pain
  33. Letter to the Editor
  34. Reply to Letter to the Editor “Clinical registries are essential tools for ensuring quality and improving outcomes in pain medicine” by Baciarello et al.
Heruntergeladen am 3.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/sjpain-2019-0040/html?lang=de
Button zum nach oben scrollen